{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T14:00:39Z","timestamp":1777039239709,"version":"3.51.4"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Exp Mol Med"],"published-print":{"date-parts":[[2020,9]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Psoriasis is one of the most common immune-mediated chronic inflammatory skin diseases. However, little is known about the molecular mechanism underlying the immunological circuits that maintain innate and adaptive immune responses in established psoriasis. In this study, we found that the Pellino1 (Peli1) ubiquitin E3 ligase is activated by innate pattern-recognition receptors (PRRs), such as Toll-like receptors (TLRs), and is highly upregulated in human psoriatic skin lesions and murine psoriasis-like models. Increased Peli1 expression is strongly correlated with the immunopathogenesis of psoriasis by activating hyperproliferation of keratinocytes in the S and G2\/M phases of the cell cycle and promoting chronic skin inflammation. Furthermore, Peli1-induced psoriasis-like lesions showed significant changes in the expression levels of several T helper 17 (Th17)-related cytokines, such as IL-17a, IL-21, IL-22, IL-23, and IL-24, indicating that overexpression of Peli1 resulted in the sequential engagement of the Th17 cell response. However, the overexpression of Peli1 in T cells was insufficient to trigger psoriasis, while T cells were indispensable for disease manifestation. In summary, our findings demonstrate that Peli1 is a critical cell cycle activator of innate immunity, which subsequently links Th17 cell immune responses to the psoriatic microenvironment.<\/jats:p>","DOI":"10.1038\/s12276-020-00489-4","type":"journal-article","created":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T10:03:45Z","timestamp":1598954625000},"page":"1537-1549","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Pellino1 promotes chronic inflammatory skin disease via keratinocyte hyperproliferation and induction of the T helper 17 response"],"prefix":"10.1038","volume":"52","author":[{"given":"Suhyeon","family":"Kim","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Si-Yeon","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seoyoon","family":"Bae","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jin-Kwan","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kyungrim","family":"Hwang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heounjeong","family":"Go","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chang-Woo","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,9,1]]},"reference":[{"key":"489_CR1","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.jaut.2015.07.008","volume":"64","author":"JL Harden","year":"2015","unstructured":"Harden, J. L., Krueger, J. G. & Bowcock, A. M. The immunogenetics of Psoriasis: a comprehensive review. J. Autoimmun. 64, 66\u201373 (2015).","journal-title":"J. Autoimmun."},{"key":"489_CR2","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.it.2012.11.005","volume":"34","author":"MA Lowes","year":"2013","unstructured":"Lowes, M. A., Russell, C. B., Martin, D. A., Towne, J. E. & Krueger, J. G. The IL-23\/T17 pathogenic axis in psoriasis is amplified by keratinocyte responses. Trends Immunol. 34, 174\u2013181 (2013).","journal-title":"Trends Immunol."},{"key":"489_CR3","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1056\/NEJMra0804595","volume":"361","author":"FO Nestle","year":"2009","unstructured":"Nestle, F. O., Kaplan, D. H. & Barker, J. Psoriasis. N. Engl. J. Med. 361, 496\u2013509 (2009).","journal-title":"N. Engl. J. Med."},{"key":"489_CR4","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1084\/jem.20050500","volume":"202","author":"FO Nestle","year":"2005","unstructured":"Nestle, F. O. et al. Plasmacytoid predendritic cells initiate psoriasis through interferon-alpha production. J. Exp. Med. 202, 135\u2013143 (2005).","journal-title":"J. Exp. Med."},{"key":"489_CR5","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1038\/jid.2008.194","volume":"129","author":"LC Zaba","year":"2009","unstructured":"Zaba, L. C. et al. Psoriasis is characterized by accumulation of immunostimulatory and Th1\/Th17 cell-polarizing myeloid dendritic cells. J. Invest. Dermatol. 129, 79\u201388 (2009).","journal-title":"J. Invest. Dermatol."},{"key":"489_CR6","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1038\/jid.2011.262","volume":"132","author":"M Kennedy-Crispin","year":"2012","unstructured":"Kennedy-Crispin, M. et al. Human keratinocytes\u2019 response to injury upregulates CCL20 and other genes linking innate and adaptive immunity. J. Invest. Dermatol. 132, 105\u2013113 (2012).","journal-title":"J. Invest. Dermatol."},{"key":"489_CR7","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1038\/ni.f.213","volume":"9","author":"SK Bromley","year":"2008","unstructured":"Bromley, S. K., Mempel, T. R. & Luster, A. D. Orchestrating the orchestrators: chemokines in control of T cell traffic. Nat. Immunol. 9, 970\u2013980 (2008).","journal-title":"Nat. Immunol."},{"key":"489_CR8","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1111\/imr.12298","volume":"266","author":"AE Medvedev","year":"2015","unstructured":"Medvedev, A. E., Murphy, M., Zhou, H. & Li, X. E3 ubiquitin ligases Pellinos as regulators of pattern recognition receptor signaling and immune responses. Immunol. Rev. 266, 109\u2013122 (2015).","journal-title":"Immunol. Rev."},{"key":"489_CR9","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1038\/ni.1863","volume":"11","author":"T Kawai","year":"2010","unstructured":"Kawai, T. & Akira, S. The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors. Nat. Immunol. 11, 373\u2013384 (2010).","journal-title":"Nat. Immunol."},{"key":"489_CR10","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1038\/nri3446","volume":"13","author":"LA O\u2019Neill","year":"2013","unstructured":"O\u2019Neill, L. A., Golenbock, D. & Bowie, A. G. The history of Toll-like receptors - redefining innate immunity. Nat. Rev. Immunol. 13, 453\u2013460 (2013).","journal-title":"Nat. Rev. Immunol."},{"key":"489_CR11","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1080\/08830185.2016.1261318","volume":"36","author":"S Tartey","year":"2017","unstructured":"Tartey, S. & Takeuchi, O. Pathogen recognition and Toll-like receptor targeted therapeutics in innate immune cells. Int. Rev. Immunol. 36, 57\u201373 (2017).","journal-title":"Int. Rev. Immunol."},{"key":"489_CR12","doi-asserted-by":"publisher","first-page":"66656","DOI":"10.18632\/oncotarget.19105","volume":"8","author":"J Li","year":"2017","unstructured":"Li, J., Yang, F., Wei, F. & Ren, X. The role of toll-like receptor 4 in tumor microenvironment. Oncotarget 8, 66656\u201366667 (2017).","journal-title":"Oncotarget"},{"key":"489_CR13","doi-asserted-by":"publisher","first-page":"4976","DOI":"10.1172\/JCI75667","volume":"124","author":"HY Park","year":"2014","unstructured":"Park, H. Y. et al. Pellino 1 promotes lymphomagenesis by deregulating BCL6 polyubiquitination. J. Clin. Invest. 124, 4976\u20134988 (2014).","journal-title":"J. Clin. Invest."},{"key":"489_CR14","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1111\/imr.12306","volume":"266","author":"F Humphries","year":"2015","unstructured":"Humphries, F. & Moynagh, P. N. Molecular and physiological roles of Pellino E3 ubiquitin ligases in immunity. Immunol. Rev. 266, 93\u2013108 (2015).","journal-title":"Immunol. Rev."},{"key":"489_CR15","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1038\/nri3599","volume":"14","author":"PN Moynagh","year":"2014","unstructured":"Moynagh, P. N. The roles of Pellino E3 ubiquitin ligases in immunity. Nat. Rev. Immunol. 14, 122\u2013131 (2014).","journal-title":"Nat. Rev. Immunol."},{"key":"489_CR16","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1038\/ni.1777","volume":"10","author":"M Chang","year":"2009","unstructured":"Chang, M., Jin, W. & Sun, S. C. Peli1 facilitates TRIF-dependent Toll-like receptor signaling and proinflammatory cytokine production. Nat. Immunol. 10, 1089\u20131095 (2009).","journal-title":"Nat. Immunol."},{"key":"489_CR17","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1038\/ni.2090","volume":"12","author":"M Chang","year":"2011","unstructured":"Chang, M. et al. The ubiquitin ligase Peli1 negatively regulates T cell activation and prevents autoimmunity. Nat. Immunol. 12, 1002\u20131009 (2011).","journal-title":"Nat. Immunol."},{"key":"489_CR18","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1038\/cmi.2011.60","volume":"9","author":"W Jin","year":"2012","unstructured":"Jin, W., Chang, M. & Sun, S. C. Peli: a family of signal-responsive E3 ubiquitin ligases mediating TLR signaling and T-cell tolerance. Cell Mol. Immunol. 9, 113\u2013122 (2012).","journal-title":"Cell Mol. Immunol."},{"key":"489_CR19","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.jaci.2010.10.024","volume":"127","author":"KJ Baines","year":"2011","unstructured":"Baines, K. J., Simpson, J. L., Wood, L. G., Scott, R. J. & Gibson, P. G. Transcriptional phenotypes of asthma defined by gene expression profiling of induced sputum samples. J. Allergy Clin. Immunol. 127, 153\u2013160 (2011). 160 e151-159.","journal-title":"J. Allergy Clin. Immunol."},{"key":"489_CR20","doi-asserted-by":"publisher","first-page":"4697","DOI":"10.1016\/j.febslet.2006.07.046","volume":"580","author":"R Schauvliege","year":"2006","unstructured":"Schauvliege, R., Janssens, S. & Beyaert, R. Pellino proteins are more than scaffold proteins in TLR\/IL-1R signalling: a role as novel RING E3-ubiquitin-ligases. FEBS Lett. 580, 4697\u20134702 (2006).","journal-title":"FEBS Lett."},{"key":"489_CR21","doi-asserted-by":"publisher","first-page":"3138","DOI":"10.1002\/eji.201343801","volume":"43","author":"B Flutter","year":"2013","unstructured":"Flutter, B. & Nestle, F. O. TLRs to cytokines: mechanistic insights from the imiquimod mouse model of psoriasis. Eur. J. Immunol. 43, 3138\u20133146 (2013).","journal-title":"Eur. J. Immunol."},{"key":"489_CR22","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1038\/nri1957","volume":"6","author":"A Marshak-Rothstein","year":"2006","unstructured":"Marshak-Rothstein, A. Toll-like receptors in systemic autoimmune disease. Nat. Rev. Immunol. 6, 823\u2013835 (2006).","journal-title":"Nat. Rev. Immunol."},{"key":"489_CR23","doi-asserted-by":"publisher","first-page":"437246","DOI":"10.1155\/2010\/437246","volume":"2010","author":"A Hari","year":"2010","unstructured":"Hari, A., Flach, T. L., Shi, Y. & Mydlarski, P. R. Toll-like receptors: role in dermatological disease. Mediat. Inflamm. 2010, 437246 (2010).","journal-title":"Mediat. Inflamm."},{"key":"489_CR24","doi-asserted-by":"publisher","first-page":"5836","DOI":"10.4049\/jimmunol.0802999","volume":"182","author":"L van der Fits","year":"2009","unstructured":"van der Fits, L. et al. Imiquimod-induced psoriasis-like skin inflammation in mice is mediated via the IL-23\/IL-17 axis. J. Immunol. 182, 5836\u20135845 (2009).","journal-title":"J. Immunol."},{"key":"489_CR25","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1111\/1346-8138.12367","volume":"41","author":"A Ueyama","year":"2014","unstructured":"Ueyama, A. et al. Mechanism of pathogenesis of imiquimod-induced skin inflammation in the mouse: a role for interferon-alpha in dendritic cell activation by imiquimod. J. Dermatol. 41, 135\u2013143 (2014).","journal-title":"J. Dermatol."},{"key":"489_CR26","doi-asserted-by":"publisher","first-page":"e7703","DOI":"10.1371\/journal.pone.0007703","volume":"4","author":"EY Zhang","year":"2009","unstructured":"Zhang, E. Y., Chen, A. Y. & Zhu, B. T. Mechanism of dinitrochlorobenzene-induced dermatitis in mice: role of specific antibodies in pathogenesis. PLoS ONE 4, e7703 (2009).","journal-title":"PLoS ONE"},{"key":"489_CR27","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.coi.2017.08.008","volume":"48","author":"E Guttman-Yassky","year":"2017","unstructured":"Guttman-Yassky, E. & Krueger, J. G. Atopic dermatitis and psoriasis: two different immune diseases or one spectrum? Curr. Opin. Immunol. 48, 68\u201373 (2017).","journal-title":"Curr. Opin. Immunol."},{"key":"489_CR28","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1097\/MCP.0000000000000005","volume":"20","author":"AD Parulekar","year":"2014","unstructured":"Parulekar, A. D., Atik, M. A. & Hanania, N. A. Periostin, a novel biomarker of TH2-driven asthma. Curr. Opin. Pulm. Med. 20, 60\u201365 (2014).","journal-title":"Curr. Opin. Pulm. Med."},{"key":"489_CR29","doi-asserted-by":"publisher","first-page":"563","DOI":"10.2332\/allergolint.10-OA-0297","volume":"61","author":"H Shiraishi","year":"2012","unstructured":"Shiraishi, H. et al. Periostin contributes to the pathogenesis of atopic dermatitis by inducing TSLP production from keratinocytes. Allergol. Int. 61, 563\u2013572 (2012).","journal-title":"Allergol. Int."},{"key":"489_CR30","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1038\/ng.311","volume":"41","author":"RP Nair","year":"2009","unstructured":"Nair, R. P. et al. Genome-wide scan reveals association of psoriasis with IL-23 and NF-kappaB pathways. Nat. Genet. 41, 199\u2013204 (2009).","journal-title":"Nat. Genet."},{"key":"489_CR31","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1038\/nm1162","volume":"11","author":"S Sano","year":"2005","unstructured":"Sano, S. et al. Stat3 links activated keratinocytes and immunocytes required for development of psoriasis in a novel transgenic mouse model. Nat. Med. 11, 43\u201349 (2005).","journal-title":"Nat. Med."},{"key":"489_CR32","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1016\/j.rdc.2015.07.013","volume":"41","author":"WH Boehncke","year":"2015","unstructured":"Boehncke, W. H. Etiology and pathogenesis of psoriasis. Rheum. Dis. Clin. N. Am. 41, 665\u2013675 (2015).","journal-title":"Rheum. Dis. Clin. N. Am."},{"key":"489_CR33","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1038\/nature05663","volume":"445","author":"MA Lowes","year":"2007","unstructured":"Lowes, M. A., Bowcock, A. M. & Krueger, J. G. Pathogenesis and therapy of psoriasis. Nature 445, 866\u2013873 (2007).","journal-title":"Nature"},{"key":"489_CR34","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1016\/j.clindermatol.2007.08.016","volume":"25","author":"AS Buchau","year":"2007","unstructured":"Buchau, A. S. & Gallo, R. L. Innate immunity and antimicrobial defense systems in psoriasis. Clin. Dermatol. 25, 616\u2013624 (2007).","journal-title":"Clin. Dermatol."},{"key":"489_CR35","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1038\/nm.1995","volume":"15","author":"R Caruso","year":"2009","unstructured":"Caruso, R. et al. Involvement of interleukin-21 in the epidermal hyperplasia of psoriasis. Nat. Med. 15, 1013\u20131015 (2009).","journal-title":"Nat. Med."},{"key":"489_CR36","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1016\/j.immuni.2013.10.009","volume":"39","author":"S Kumari","year":"2013","unstructured":"Kumari, S. et al. Tumor necrosis factor receptor signaling in keratinocytes triggers interleukin-24-dependent psoriasis-like skin inflammation in mice. Immunity 39, 899\u2013911 (2013).","journal-title":"Immunity"},{"key":"489_CR37","doi-asserted-by":"publisher","first-page":"6595","DOI":"10.1128\/JVI.06755-11","volume":"86","author":"JA Bennett","year":"2012","unstructured":"Bennett, J. A. et al. Pellino-1 selectively regulates epithelial cell responses to rhinovirus. J. Virol. 86, 6595\u20136604 (2012).","journal-title":"J. Virol."},{"key":"489_CR38","doi-asserted-by":"publisher","first-page":"1785","DOI":"10.1038\/jid.2010.103","volume":"130","author":"BB Davidovici","year":"2010","unstructured":"Davidovici, B. B. et al. Psoriasis and systemic inflammatory diseases: potential mechanistic links between skin disease and co-morbid conditions. J. Invest. Dermatol. 130, 1785\u20131796 (2010).","journal-title":"J. Invest. Dermatol."}],"container-title":["Experimental &amp; Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s12276-020-00489-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s12276-020-00489-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s12276-020-00489-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:07:55Z","timestamp":1630454875000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s12276-020-00489-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":38,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2020,9]]}},"alternative-id":["489"],"URL":"https:\/\/doi.org\/10.1038\/s12276-020-00489-4","relation":{},"ISSN":["1226-3613","2092-6413"],"issn-type":[{"value":"1226-3613","type":"print"},{"value":"2092-6413","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9]]},"assertion":[{"value":"10 December 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 July 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 July 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 September 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}